Article 03 Sep 2024 Federal Circuit Clarifies Obviousness-Type Double Patenting Rule United States IP
Article 31 May 2024 USPTO Issues Proposed Rule On A New Terminal Disclaimer Requirement United States IP
Article 28 Sep 2021 FDA Seeks To Deepen Engagement With USPTO On Pharmaceutical Patents United States IP